Literature DB >> 17266093

Sleep-related stridor due to dystonic vocal cord motion and neurogenic tachypnea/tachycardia in multiple system atrophy.

Roberto Vetrugno1, Rocco Liguori, Pietro Cortelli, Giuseppe Plazzi, Claudio Vicini, Aldo Campanini, Roberto D'Angelo, Federica Provini, Pasquale Montagna.   

Abstract

Sleep-disordered breathing and sleep-related motor phenomena are part of the clinical spectrum of multiple system atrophy (MSA). Stridor has been attributed to denervation of laryngeal muscles or instead to dystonic vocal cord motion. We studied 3 patients with nocturnal stridor in the setting of MSA. All patients underwent nocturnal videopolysomnography (VPSG) with breathing and heart rate, O(2) saturation and intra-esophageal pressure recordings, and simultaneous EMG recordings of the posterior cricoarytenoid, cricothyroid, and thyroarytenoid muscles and continuous vocal cord motion evaluation by means of fiberoptic laryngoscopy. VPSG/EMG and fiberoptic laryngoscopy documented normal vocal cord motion without denervation during wake and stridor only during sleep when hyperactivation of vocal cords adductors appeared in the absence of significant O(2) desaturation. All patients had tachycardia and tachypnea and paradoxical breathing during sleep, erratic intercostalis and diaphragmatic EMG activity and Rem sleep behavior disorder. One of the patients had restless legs syndrome with periodic limb movement during sleep and excessive fragmentary hypnic myoclonus. In conclusion, our patients with MSA had nocturnal stridor due to sleep-related laryngeal dystonia. Stridor was associated with other abnormal sleep-related respiratory and motor disorders, suggesting an impairment of homeostatic brainstem integration in MSA.

Entities:  

Mesh:

Year:  2007        PMID: 17266093     DOI: 10.1002/mds.21384

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  19 in total

Review 1.  Orthostatic hypotension: managing a difficult problem.

Authors:  Pearl K Jones; Brett H Shaw; Satish R Raj
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-01

Review 2.  Sleep-disordered breathing in neurodegenerative diseases.

Authors:  Carles Gaig; Alex Iranzo
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 3.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

4.  Multiple system atrophy: current and future approaches to management.

Authors:  Olivier Flabeau; Wassilios G Meissner; François Tison
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

5.  Reversible sleep-related stridor during vagus nerve stimulation.

Authors:  Erik K St Louis; Kevin Faber
Journal:  Epileptic Disord       Date:  2010-03-01       Impact factor: 1.819

Review 6.  Sleep Abnormalities in MultipleSystem Atrophy.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

7.  Sleep dysfunction in multiple system atrophy.

Authors:  Luigi Ferini-Strambi; Sara Marelli
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

8.  Effects of continuous positive airway pressure on stridor in multiple system atrophy-sleep laryngoscopy.

Authors:  Tomasz J Kuźniar; Timothy I Morgenthaler; Udaya B S Prakash; John F Pallanch; Michael H Silber; Maja Tippmann-Peikert
Journal:  J Clin Sleep Med       Date:  2009-02-15       Impact factor: 4.062

9.  Clinical and polysomnographic features of patients with multiple system atrophy in Southwest China.

Authors:  Xiao Yan Guo; Bei Cao; Fei Lei; Lili Huang; Ke Chen; Wei Song; Bi Zhao; Xiangdong Tang; Huifang Shang
Journal:  Sleep Breath       Date:  2013-04-06       Impact factor: 2.816

10.  Parabrachial nucleus involvement in multiple system atrophy.

Authors:  E E Benarroch; A M Schmeichel; P A Low; J E Parisi
Journal:  Auton Neurosci       Date:  2013-05-09       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.